Pull to refresh
Logo
Daily Brief
Following
Why Ranks Sign Up
Insilico Medicine

Insilico Medicine

Biopharmaceutical Company

Appears in 1 story

Stories

AI transforms drug discovery from years to hours

New Capabilities

Lead clinical-stage AI drug developer; Phase III for rentosertib expected Q4 2026; signed $2.5 billion neuroimmune collaboration with SK Biopharmaceuticals in June 2026

In January 2026, Tsinghua University researchers published DrugCLIP in Science, a system that screened 500 million drug compounds against 10,000 human proteins in under 24 hours on eight GPUs. The approach is 10 million times faster than conventional molecular docking, and the results are public in GenomeScreenDB, covering roughly half the human genome.

Updated Jun 27